Dr. Mehdi Brahmi
Claim this profileCentre Léon Bérard
Studies Solid Tumors
Studies Malignant Pleural Mesothelioma
2 reported clinical trials
2 drugs studied
Area of expertise
1Solid Tumors
Stage IV
ARID1A positive
Stage III
2Malignant Pleural Mesothelioma
Stage IV
ARID1A positive
Stage III
Clinical Trials Mehdi Brahmi is currently running
CPI-0209
for Cancer and Lymphoma
The purpose of this open-label, first-in-human (FIH) trial is to evaluate the safety, tolerability, and preliminary clinical activity of Tulmimetostat as a monotherapy in patients with advanced solid tumors and lymphomas.
Recruiting1 award Phase 1 & 28 criteria
NB003
for Solid Cancer
This trial tests NB003, a new drug, for safety and behavior in patients with advanced cancers who have limited treatment options. It targets specific genetic changes in cancer cells to potentially stop or slow down their growth.
Recruiting1 award Phase 1
More about Mehdi Brahmi
Clinical Trial Related6 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Mehdi Brahmi has experience with
- NB003
- CPI-0209
Breakdown of trials Mehdi Brahmi has run
Malignant Pleural Mesothelioma
Prostate Cancer
Endometrial Cancer
Mixed-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mehdi Brahmi specialize in?
Mehdi Brahmi focuses on Solid Tumors and Malignant Pleural Mesothelioma. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are ARID1A positive.
Is Mehdi Brahmi currently recruiting for clinical trials?
Yes, Mehdi Brahmi is currently recruiting for 2 clinical trials in Lyon cedex 08 Rhone. If you're interested in participating, you should apply.
Are there any treatments that Mehdi Brahmi has studied deeply?
Yes, Mehdi Brahmi has studied treatments such as NB003, CPI-0209.
What is the best way to schedule an appointment with Mehdi Brahmi?
Apply for one of the trials that Mehdi Brahmi is conducting.
What is the office address of Mehdi Brahmi?
The office of Mehdi Brahmi is located at: Centre Léon Bérard, Lyon cedex 08, Rhone 69373 France. This is the address for their practice at the Centre Léon Bérard.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.